Tris Pharma
George Wang is an experienced professional in the field of analytical development, currently serving as the Director of Analytical Development at Tris Pharma since August 2021. Prior to this role, George held positions at Bristol-Myers Squibb from December 2016 to December 2021 as an Analytical Lead, where responsibilities included managing analytical projects, coordinating outsourced support, and providing analytical CMC support for IND stage projects. George's earlier tenure at Bristol-Myers Squibb from March 2003 to May 2016 saw leadership roles in analytical R&D and method development. Initial career experiences include serving as a Senior Scientist at Rhodia. Academic credentials include a PhD in Chemistry from Princeton University and a BS in Polymer Chemistry and Physics from the University of Science and Technology of China. George possesses extensive expertise in chromatographic and spectroscopic techniques.
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.